Skip to main content
TP53 mutations predict inferior outcomes in newly diagnosed aggressive BCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
TP53 mutations predict inferior outcomes in newly diagnosed aggressive BCL
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Antineoplastic Drug
0
1
Biologic Therapy
0
1
Monoclonal Antibody
0
0.95
Leukemia
0
0.27
Cancer
0
0.11
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Edit Tags